Auhtors: Seyfried TN, Shivane AG, Kalamian M, Maroon JC, Mukherjee P, Zuccoli G PMID: 34136522 PMCID: PMC8200410 DOI: 10.3389/fnut.2021.682243 Abstract Background: Successful treatment of glioblastoma (GBM) remains futile despite decades of intense research. GBM is similar to most other malignant cancers in requiring glucose and glutamine for growth, regardless of histological or genetic heterogeneity. Ketogenic [...]

Authors: Hamilton D, Jensen GS PMID: 33882028 Abstract Objectives: To evaluate the effects of ATP 360, a nutraceutical energy formula, in people experiencing long-term fatigue affecting daily living. To explore the use of ex vivo mitochondrial stress testing to evaluate cellular energy improvements with nutraceutical support. Study design: An open-label study design was used with [...]

Auhtors: GBD 2019 Tobacco Collaborators PMID: 34051883 PMCID: PMC8223261 DOI: 10.1016/S0140-6736(21)01169-7 Abstract Background: Ending the global tobacco epidemic is a defining challenge in global health. Timely and comprehensive estimates of the prevalence of smoking tobacco use and attributable disease burden are needed to guide tobacco control efforts nationally and globally. Methods: We estimated the prevalence [...]

Authors: Chen T, Song J, Liu H, Zheng H, Chen C PMID: 34035353 PMCID: PMC8149409 DOI: 10.1038/s41598-021-90351-y Abstract The objective of this study was to detect the Epstein-Barr virus (EBV) coinfection in coronavirus disease 2019 (COVID-19). In this retrospective single-center study, we included 67 COVID-19 patients with onset time within 2 weeks in Renmin Hospital [...]

Authors: Hannan MA PMID: 34073784 doi: 10.3390/nu13061784 Abstract Mounting evidence support the potential benefits of functional foods or nutraceuticals for human health and diseases. Black cumin (Nigella sativa L.), a highly valued nutraceutical herb with a wide array of health benefits, has attracted growing interest from health-conscious individuals, the scientific community, and pharmaceutical industries. The [...]

Authors: Giannis D, allen SL, Tsang J, Flint S, Pinhasov T, Williams S PMID: 33824972 PMCID: PMC8032474 DOI: 10.1182/blood.2020010529 Abstract Thromboembolic events, including venous thromboembolism (VTE) and arterial thromboembolism (ATE), and mortality from subclinical thrombotic events occur frequently in coronavirus disease 2019 (COVID-19) inpatients. Whether the risk extends postdischarge has been controversial. Our prospective registry [...]

Authors: Chen CX, Wang JJ, Li H, Yuan LT, Gale RP PMID: 33990684 PMCID: PMC8119232 DOI: 10.1038/s41375-021-01266-6 Abstract We analyzed reports on safety and efficacy of JAK-inhibitors in patients with coronavirus infectious disease-2019 (COVID-19) published between January 1st and March 6th 2021 using the Newcastle-Ottawa and Jadad scales for quality assessment. We used disease severity [...]

Authors: Zhang J, Rao X, Li Y, Zhu Y, Liu G, Guo G et al. PMID: 34106642 PMCID: PMC8133047 DOI: 10.1097/MD.0000000000025876 Abstract Background: Patients infected with a virus usually lack vitamin C. High-dose vitamin C has an antiviral effect, and has been used by several researchers to treat COVID-19 by intravenous infusion, achieving good results. [...]

Authors:da Silva JK, Figueirdo PL, Byler KG, setzer WN. PMID:PMC7279430 DOI: 10.3390/ijms21103426 Abstract Essential oils have shown promise as antiviral agents against several pathogenic viruses. In this work we hypothesized that essential oil components may interact with key protein targets of the 2019 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). A molecular docking analysis was [...]

Authors: Seneff S, Nigh G AbstractOperation Warp Speed brought to market in the United States two mRNA vaccines, produced by Pfizer and Moderna. Interim data suggested high efficacy for both of these vaccines, which helped legitimize Emergency Use Authorization (EUA) by the FDA. However, the exceptionally rapid movement of these vaccines through controlled trials [...]